Evaluation of Pharmacokinetics, Safety, And Tolerability Of PF-04971729 In Japanese And Western Healthy Subjects



Status:Archived
Conditions:Diabetes
Therapuetic Areas:Endocrinology
Healthy:No
Age Range:Any
Updated:7/1/2011
Start Date:October 2010
End Date:February 2011

Use our guide to learn which trials are right for you!

A Phase 1, Randomized, Double Blind, Placebo-Controlled, Parallel Cohort, Single Dose Escalation And Multiple Dose Study In Japanese Healthy Subjects, And Open Label, Single Dose Escalation Study In Western Healthy Subjects To Investigate The Safety, Tolerability, Pharmacokinetics, And Pharmacodynamics Of PF-04971729


This study is to characterize the pharmacokinetics, safety, tolerability and
pharmacodynamics of single and multiple oral doses of PF-04971729 in Japanese healthy
subjects. The secondary objective is to investigate the safety, tolerability,
pharmacokinetics and pharmacodynamics of single doses of PF-04971729 in Western healthy
subjects as compared to Japanese healthy subjects



We found this trial at
1
site
Bridgeport, Connecticut 06606
?
mi
from
Bridgeport, CT
Click here to add this to my saved trials